Scrip M&A Podcast: Assessing The Biopharma Deals Environment At Midyear

 
• By Joseph Haas, Kevin Grogan, and Mandy Jackson
  
Midyear M&A podcast
Scrip editors look ahead to biopharma dealmaking in the second half of 2024 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business